A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells

Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells

(2010) Yusuke Tomita et al.   CANCER SCIENCE

Identification of SPARC as a candidate target antigen for immunotherapy of various cancers

(2010) Mitsuhiro Inoue et al.   INTERNATIONAL JOURNAL OF CANCER

Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer

(2009) Koji Kono et al.   CANCER SCIENCE

The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication

(2009) Tomás Aparicio et al.   NUCLEIC ACIDS RESEARCH

mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue

(2008) Jian-na Li et al.   BMC CANCER

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

(2008) K. Imai et al.   CLINICAL CANCER RESEARCH

Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer

(2008) Pedro Romero   Clinical Lung Cancer

Conclusion

(2008) P. A. Bunn et al.   ONCOLOGIST

Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8+ T Lymphocytes

(2008) P. A. Savage et al.   SCIENCE